title: [Gastrointestinal stromal tumors: our experience].
abstract: The authors report their experience on the treatment of GIST. They point out the importance of classification of the disease in low, medium and high risk neoplasms based on the characteristic of the tumour: site, volume and mytotic index as the Consensus Conference of Bethesda recently established. Surgical procedure remains the most important treatment in localized disease, while patients with advanced disease can benefit from imatinib, a chemotherapeutic agent recently introduced, as an adjuvant therapy.
authors.affiliation: Ospedale San Carlo, IDI Sanità, Roma.
authors.forename: E
authors.initials: E
authors.lastname: Nanni
authors.forename: M
authors.initials: M
authors.lastname: Elia
authors.forename: E
authors.initials: E
authors.lastname: De Ruvo
authors.forename: C
authors.initials: C
authors.lastname: Montalti
authors.forename: B
authors.initials: B
authors.lastname: Masci
authors.forename: G
authors.initials: G
authors.lastname: Mezzetti
authors.forename: S
authors.initials: S
authors.lastname: Stefanini
authors.forename: V
authors.initials: V
authors.lastname: Casaldi
mesh_terms: D000368:Aged; D046152:Gastrointestinal Stromal Tumors / Q000601:surgery*; D006801:Humans; D008875:Middle Aged